Evrópusambandið - króatíska - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastična sredstva - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Evrópusambandið - króatíska - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateron acetat - prostatske neoplazme - endokrinska terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Evrópusambandið - króatíska - EMA (European Medicines Agency)

serb sas - glucarpidase - metabolic side effects of drugs and substances - svi ostali terapeutski proizvodi - voraxaze is indicated to reduce toxic plasma methotrexate concentration in adults and children (aged 28 days and older) with delayed methotrexate elimination or at risk of methotrexate toxicity.

Evrópusambandið - króatíska - EMA (European Medicines Agency)

novo nordisk a/s - semaglutide - obesity; overweight - pripravci protiv pretilosti, isključujući. prehrambeni proizvodi - wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial body mass index (bmi) of- ≥30 kg/m² (obesity), or- ≥27 kg/m² to.

Evrópusambandið - króatíska - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - difelikefalin - pruritus - svi ostali terapeutski proizvodi - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.

Evrópusambandið - króatíska - EMA (European Medicines Agency)

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - agenti imaju antikancerogena - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.

Svartfjallaland - króatíska - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"merck" d.o.o. beograd - dio stranog druŠtva u podgorici - interferon beta-1a - rastvor za injekciju u napunjenom injekcionom špricu - 44mcg/0.5ml

Svartfjallaland - króatíska - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"merck" d.o.o. beograd - dio stranog druŠtva u podgorici - avelumab - koncentrat za rastvor za infuziju - 20mg/ml

Svartfjallaland - króatíska - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"merck" d.o.o. beograd - dio stranog druŠtva u podgorici - folitropin alfa, lutropin alfa - prašak i rastvarač za rastvor za injekciju - 150i.j. + 75i.j.

Svartfjallaland - króatíska - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

"merck" d.o.o. beograd - dio stranog druŠtva u podgorici - interferon beta-1a - rastvor za injekciju u napunjenom injekcionom špricu - 22mcg/0.5ml